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Abstract-We examined the feasibility and the proportional trade-off assumption of the 
Time Trade-Off method. Utilities were assessed of the actual health states of 54 testicular 
and 72 colorectal cancer patients, treated with the curative intent and 29 incurable 
colorectal cancer patients. Three periods of time were used to assess proportionality: the 
subject’s life expectancy and two shorter periods. Results showed the method to be 
feasible in curatively treated patients, though the use of life expectancy posed difficulties 
in some very old subjects. This same difficulty was encountered in patients with 
symptomatic incurable disease. A two step procedure is proposed as a solution. The 
proportional trade-off assumption was violated. Utilities for the longer period were 
smaller than those for the shorter periods. Life expectancy and trade-off did not 
correlate, though. Remarkable was that many patients were unwilling to trade at all. 
The implications of the findings are discussed. 
Utility assessment Time Trade-Off 
preferences Feasibility 
INTRODUCTION 
In medical decision-making the concept of qual- 
ity-adjusted life years (QALYs) is often used. 
The quality-adjustment factor, which represents 
the subjective value that individuals assign to 
outcomes of decisions under uncertainty, is 
called the utility. A method often used to 
measure utilities is the Time Trade-Off (TTO), 
which was developed specifically for the field of 
health care by Torrance et al. [ 11. In the TTO the 
subject is asked how much time x in a state of 
perfect health he or she considers equivalent to 
a period t in his or her current health state 
(usually worse than perfect health). The sim- 
plest-and most frequently used-way of trans- 
forming the perfect health equivalent x to a 
QALY Oncology Health state 
utility (ranging from 0 to 1) is to calculate a 
TTO-score x/t. A constant proportional trade- 
off is assumed when applying a TTO-score 
assessed for one period of time to other periods 
of time. This means that if an individual con- 
siders 16 years in perfect health equivalent to 20 
years in a disabled health state, he or she should 
consider 12 years in perfect health equivalent to 
15 years in this state. However, due to time 
discounting the willingness to trade off can be 
expected to depend on the length of period t [2]. 
If so, it might be useful to find a functional form 
of the relationship between TTO-scores and t, 
so as to permit adjustment to various life expec- 
tancies. 
Utility assessment has not been used 
frequently in cancer patients, even though in 
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oncology trade-offs often have to be made be- 
tween quality of life and length of life. In a 
previous study [3] we used the TTO in testicular 
cancer patients to elicit utilities for health states 
that were related to testicular cancer, but hypo- 
thetical at the time of the assessment. In this 
particular patient group with a very good prog- 
nosis (patients had been disease free for over 2 
years), the method proved feasible to elicit the 
utilities of hypothetical health states. In the 
present study we wished to explore the use of 
this method in the evaluation of the actual 
situation of cancer patients, both in patients 
with a good prognosis and in patients with a 
poor prognosis. In this latter group utility elici- 
tation might be especially relevant, as the weigh- 
ing of quality and length of life is more pertinent 
in a situation where cure is not possible any 
longer. 
The first purpose of the study was to assess 
the feasibility of the TTO for the valuation of 
health states actually experienced by cancer 
patients: is the method acceptable and not too 
difficult, both for respondents and interviewers? 
More in particular, does the use of life 
expectancy-inevitable in the method-pose 
difficulties in patients with incurable disease? 
The second purpose was to assess whether TTO- 
scores depend on the length of the period t. We 
tested this in two ways. In the first place, we 
compared TTO-scores for three periods t (intra- 
respondent). Our hypothesis was that due to 
time discounting respondents would be willing 
to trade off a larger proportion off longer 
periods than off shorter. In the second place, we 
investigated whether people in the same health 
state but with longer life expectancies were more 




We interviewed three groups of cancer 
patients. The first group consisted of consecu- 
tive testicular cancer patients with a good prog- 
nosis who had received treatment in the 
previous 2 years, or were still receiving treat- 
ment for their disease, in the Daniel den Hoed 
Clinic, Rotterdam, the University Hospital 
Leiden, or the Hospital of the Free University, 
Amsterdam. Fifty-eight non-seminomatous 
germ cell testicular cancer patients were ap- 
proached, 54 patients agreed to participate 
(93%). The second group consisted of disease 
free colorectal cancer patients. These patients 
had been disease free for less than 5 years and 
were in the follow up schedule of the Dia- 
conessen Hospital or the University Hospital 
Leiden. Seventy-seven patients were selected 
through the outpatient clinic appointment sys- 
tem, of whom 72 (94%) were willing to partici- 
pate. The third group consisted of patients 
diagnosed with an incurable recurrence of a 
colorectal cancer treated at or referred to one of 
the two latter hospitals. Thirty-four patients 
were approached, of whom 29 (85%) agreed to 
participate. 
Procedures 
In all three patient groups the TTO formed 
part of an interview in which patients’ attitudes 
towards treatment or follow-up were assessed, 
as well as their quality of life and the utilities of 
their health states. The TTO elicited the number 
of years x in perfect health that the respondent 
considered equivalent to a period t in his or her 
health state during the week before. Three 
lengths were used for the period t : the subject’s 
own remaining life expectancy and two shorter 
periods. The life expectancy for the young testic- 
ular cancer group was approximated by taking 
the number of years remaining from their cur- 
rent age to the average male life expectancy at 
birth in the Netherlands, i.e. 75 years. The two 
shorter periods for the testicular cancer group 
were 20 and 5 years respectively. For the disease 
free colorectal cancer group the remaining life 
expectancy was based on Life Tables of the 
Netherlands Central Bureau of Statistics [4] and 
rounded to the nearest 5-year period. For these 
patients the length of the two shorter periods 
depended on the life expectancy of the subjects. 
For those with a life expectancy of 15 years or 
longer, periods of 10 and 3 years were used as 
the intermediate and the short length respect- 
ively (except for two relatively young subjects 
who had a life expectancy of 45 years: for them 
an intermediate period of 20 years was used). 
For those with a life expectancy of 10 years or 
less, periods of 5 and 3 years were used as the 
shorter life expectancies. 
The use of the shorter periods was explained 
to the subjects in these two groups as follows. 
Subjects were told that life expectancies are an 
average figure for a population and that their 
personal life expectancy was unknown; that the 
way in which they replied to the question might 
depend on the length of time involved; and that 
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therefore we wished to ask the same question 
three times, for three periods. 
For the incurable colorectal cancer patients, 
mostly periods of 10, 5 and 3 years were 
chosen. It was explained to the subjects that the 
interviewer was not aware of the subject’s life 
expectancy (“that probably the doctor could not 
even tell?“) and that therefore three arbitrary 
periods were used. For some subjects of whom 
the interviewer felt they were not fully aware or 
had not accepted their poor prognosis psycho- 
logically, the three periods of the disease free 
group were used, so as not to make the ques- 
tions too confronting. 
Testicular cancer patients were interviewed in 
the outpatient clinic. Colorectal cancer patients 
were interviewed at home, unless they preferred 
to be interviewed in the outpatient clinic 
(N = 4). Patients were interviewed by one of 
three interviewers (GMK, AS, or a research 
assistant). Remarks and comments made by 
the interviewees about the TTO were written 
down. 
Data analysis 
Acceptability and difficulty of the TTO 
method were appraised by counting the number 
of missing values, and the reasons for missing 
data. Remarks made by respondents that per- 
tained to acceptability were evaluated. 
Estimates of the utility of the health state 
from the three TTO questions were the number 
of years x in perfect health divided by t, the 
number of years in the actual health state (in our 
study the patients life expectancy and the two 
shorter periods). The independence of TTO- 
scores x/t and period t was evaluated in two 
ways. First, the difference in TTO-scores for the 
three periods was tested by means of the Fried- 
man test. In addition, individual trade-off pat- 
terns were tabulated. Second, the association 
between life expectancy and corresponding 
TTO-score for subjects in the same health 
state was assessed by means of Spearman’s 
rank correlation coefficient. For this latter 
analysis only TTO-scores for the long period 
have been used, as the lengths of the inter- 
mediate and short periods were the same for 
the majority of subjects in the same health 
state. 
*For this temporary health state patients were asked for the 
number of years I - x they were willing to trade off off 




Age, sex, and treatment characteristics of the 
two study groups are given in Table 1. Of the 54 
testicular cancer patients, 7 patients were inter- 
viewed between two courses of chemotherapy* 
and 47 were disease free, either after surgery 
only (N = 15), or after surgery followed by 
chemotherapy (N = 32). Of the latter, 12 had 
undergone a retroperitoneal lymph node dissec- 
tion. 
Of the 29 incurable colorectal cancer patients, 
five were undergoing chemotherapy treatment 
at the time of the interview (with very minor side 
effects). These patients were interviewed be- 
tween two courses. Thirteen of the patients were 
symptomatic (defined as patients in whom a 
recurrence would be detected based on their 
symptoms), 16 were asymptomatic (patients 
who had no symptoms that would lead to 
evaluation and detection of the metastases). 
Feasibility 
In all groups, the task often had to be ex- 
plained twice. Several patients stated that the 
questions required considerable thought. Some 
patients made remarks pertaining to the TTO 
method that offer insight into the acceptability 
of the method and the wide variation in scores 
(see Appendix). A difficulty was encountered in 
some patients with an incurable recurrence. The 
interviewer had to decide during the interview 
whether the use of a shortened life expectancy 
was too confronting or not. 
Frequencies of missing TTO-scores in the 
three study groups are given in Table 2. None 
of the testicular cancer patients had missing 
data for the TTO. 
Of the four disease free colorectal cancer 
patients who had missing values for all three 
periods, two would not answer for religious 
reasons (“Life is given and life shall be taken 
when the time is right” and “Answer a fool 
according to his folly”), for one the task was 
cognitively too difficult, and one refused be- 
cause she thought the questions nonsensical. 
For the five patients who had missing scores for 
one or two of the periods, the reason was in all 
five cases the old age of the respondent, which 
made the life expectancies too similar and the 
question too difficult to answer. 
Of the four incurable colorectal cancer 
patients who had scores for all three periods 
missing, one respondent was very ill and would 
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Table 1. Patient characteristics 
Age: mean + SD 
Sex: male 
female 
Time since surgery (months) 
Time since detection of recurrence (months) 
Testicular cancer Colorectal cancer 
(treated with (treated with Colorectal cancer 
curative intent) curative intent) (incurable) 
(N = 54) (N = 72) (N = 29) 
30 k 8 60* 12 68& 12 
54 (100%) 31 (43%) 15 (52 %) 
- 41 (57%) 14 (48%) 
16k 11 27& 16 
6k5 
only give the maximal amount of time she 
thought would be endurable in her state; for one 
respondent the task was cognitively too difficult; 
one-a missionary-found it impossible to 
imagine his remaining life being like the week 
before: he was about to return Zaire in the near 
future, and the situation there would be very 
different; finally, one subject refused pertinently 
because she thought the questions nonsensical. 
Two additional patients in this group had miss- 
ing scores for one and two of the three periods 
respectively. In both cases this was due to a very 
poor health state, for which the respondent 
would again only give the maximal endurable 
time. Thus, the problem in answering was re- 
lated to a poor medical situation in three of the 
six patients. Of the 13 recurrent cancer patients 
that were symptomatic, five (38.5%) had one or 
more scores missing. 
Proportional trade -off 
Comparison of the three periods. As the will- 
ingness to trade off might depend on the length 
of the period, three different life expectancies 
were evaluated. Our hypothesis was that respon- 
dents would be willing to trade off proportion- 
ally more off the longer periods than off the 
shorter. At the group level, this effect was 
indeed found (see Table 3), and the differences 
in TTO-scores between the three periods was 
statistically significant for the total group 
(Friedman test: p < 0.001). For all patient 
groups the median scores for the intermediate 
and short periods were 1.00, meaning that at 
least half of the subjects were not willing to 
trade off. 
The hypothesis that the TTO-scores would be 
smaller for the longer periods than for the 
shorter did not hold true for all subjects. Look- 
ing at the individual data, various patterns of 
trade-offs could be discerned (Table 4). The 
majority of our patients were not willing to 
trade off at all: 68 (49%) had TTO-scores of 
1 .OO for all three periods. A second group of 46 
patients (33%) behaved according to our hy- 
pothesis: they traded off proportionally more off 
the longest period than off the shorter. Of these, 
a large majority (29, or 21% of the total) was 
only willing to trade off off the long period, 
TTO-scores for the intermediate and short 
period being 1.00. A third group of patients (8, 
or 6%) traded off most off the short period, 
opposite to our hypothesis. Finally, a large 
group (18, or 13%) showed another pattern, e.g. 
were willing to trade off off the long and short 
periods, but not on the middle. 
From Table 4 it can be seen that patients with 
an incurable recurrence were more willing to 
trade off than the others: 35% were unwilling to 
trade off at all, whereas for the other patients 
this was 51% (p > 0.10). Still, eight (35%) were 
unwilling to trade off off the short period, 
whereas in these patients this was the life expect- 
ancy that was probably the most realistic. 
Given the variety of trade-off patterns 
found, we decided not to estimate a functional 
form for the relation between period and trade- 
Off. 
Table 2. Feasibility of the Time Trade-Off method: missing data in three groups of cancer patients 
Number of respondents who had none, 
1 or 2, or all three TTO-scores missing 
N 0 1 or 2 3 
Testicular cancer (treated with curative intent) 54 54 (100%) 0 (0%) 0 (0%) 
Colorectal cancer (treated with curative intent) 72 63 (88%) 5 (7%) 4 (6%) 
Colorectal cancer (incurable) 29 23 (79%) 2 (7%) 4 (14%) 
Asymptomatic 16 15 (94%) 0 (0%) 1 (6%) 
Symptomatic 13 8 (62%) 2 (15%) 3 (23%) 
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Table 3. Time Trade-Off scores for three groups of cancer patients, for three periods (long, intermediate, 
short): means k standard deviations, and medians + interquartile ranges 
Testicular cancer Colorectal cancer 
(treated with (treated with Colorectal cancer 
curative intent) curative intent) incurable) 
TTO-scores (N = 54) (N = 63) 
Long Mean If: SD 0.93 & 0. I4 0.91 io.15(’ 
(N = 23) 
0.80 + 0.22 
median k IQR 0.99 * 0.09* 1.00 + 0.10** 0.86 + 0.40*** 
median I.e. (yr) 45.5 I5 10 
Intermediate mean k SD 0.97 k 0.09 0.96 & 0.09 0.90 + 0.16 
median + IQR I .oo + 0.03 I .oo + 0.03 I .oo & 0.20 
median I.e. 20 IO 5 
Short mean f SD 0.95 f 0.10 0.98 + 0.10 0.95 4 0. I2 
median + IQR 1.00 * 0.03 I .oo * 0 l.OO*o 
median I.e. 5 3 3 
Friedman test of differences between three periods: *p = 0.1 I; **p = 0.023; ***p = 0.001. 
Association of scores with length of period evalu- 
ated 
We hypothesized that people in the same 
health state with longer life expectancies might 
be willing to trade off proportionally more than 
people with shorter life expectancies. No corre- 
lation between length of time and willingness to 
trade off (i.e. negative correlation between 
length of time and TTO-score) was found. The 
largest correlation coefficient was 0.18, for the 
recurrent colorectal cancer group. 
DISCUSSION 
The purpose of this study was 2-fold: to assess 
whether the TTO is a feasible instrument to 
assess utilities in cancer patients of their actual 
situation, especially in patients with a poor 
prognosis, and to test whether the customary 
TTO-score x/t is similar for varying periods t. 
To our knowledge no other studies have been 
published that discuss extensively empirical 
problems of feasibility of the TTO in cancer 
patients. Torrance [5] has demonstrated its 
feasibility in the general public, Mohide [6] in 
family caregivers, Churchill [7] in end stage 
renal disease. In a former study [3] we found the 
TTO a feasible method for use in testicular 
cancer patients who could be considered cured, 
to evaluate hypothetical health states pertaining 
to testicular cancer. 
The method turned out to be feasible in the 
actual situation in testicular cancer and col- 
orectal cancer patients with a good prognosis. 
Often the questions had to be explained twice. 
However, the interviewers felt the method to 
be feasible, even though it sometimes took a 
while for subjects to grasp the concept. A 
problem was encountered in a small minority of 
subjects, who either thought the questions ridic- 
ulous, or would not answer for reasons of a 
religious nature, or for whom the questions were 
cognitively too difficult. The possibility of 
difficulties of religious nature has been put 
forward by Bursztajn and Hamm [8]. Suther- 
land et al. [9] also mention it in their discussion 
of the concept of maximal endurable time (see 
below). 
Trade-offs between quality of life and length 
of life are most relevant in those for whom cure 
is not possible anymore. In this group we en- 
countered the most problems of feasibility. In 
No trade-off 
Most traded off long period 
Off long period only 
Off long and intermediate periods 
Off long > off intermediate z off short 
Most traded off short period 
Off short period only 
Off short > off intermediate > off long 
Other trade-off pattern 
Total 
Table 4. Individual Trade-Off patterns among three groups of cancer patients on the Time Trade-Off method using three 
periods of time 
Testicular cancer Colorectal cancer 
(treated with (treated with Colorectal cancer 
curative intent) curative intent) (incurable) 
25 (46%) 35 (56%) 8 (35%) 
I5 (28%) I9 (30%) I2 (52%) 
10 (19%) I2 (19%) I (30%) 
4 (7%) 5 (8%) I (4%) 
I (2%) 2 (3%) 4 (17%) 
6 (II%) 2 (3%) 
1 (2%) 
5 (9%) 2 (3%) 
8 (15%) 7 (11%) 3 (13%) 
54 (100%) 63 (100%) 23 (100%) 
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the symptomatic recurrent cancer group almost 
40% had missing data. It seems that the clinical 
utility of the method itself is at stake. In particu- 
lar, in some of these patients the existence of a 
period of “Maximal Endurable Time” (see 
Sutherland et al. [9]) interfered with the method. 
We found that for three of our patients a 
continuation of their health state was only 
endurable for a limited period of time. They 
argued that for instance one year would be the 
maximum, whichever length of time t was 
offered. The question is whether one should 
then continue using one year as t. It would solve 
problems of feasibility (for continuing with the 
-longer- period t that had been decided upon 
beforehand is impossible in such a case), but can 
this score be compared in a valid way to scores 
of the other subjects for whom maximal en- 
durable time is not the case? 
The use of the subject’s own life expectancy 
can cause difficulties for other reasons too. Life 
tables are based on mortality rates of a large 
population, including both extremely healthy, 
“longeve” subjects, and diseased people. Life 
expectancy thus is a statistic, and perhaps not 
always meaningful to an individual. For in- 
stance, in our study there were subjects of old 
age who-when offered their statistical life ex- 
pectancies (e.g. of 10 years for a 75 year old 
man)-reported that they would not want to 
live longer than 5 years. Subsequently, in a 
TTO, these subjects would easily be willing to 
trade off 5 years to “obtain” perfect health, even 
though they only had very minor symptoms. 
This does not seem to lead to a valid TTO-score, 
though. Moreover, in some subjects with a poor 
prognosis the interviewers judged it too con- 
fronting to use the subjects’ (shortened) life 
expectancies and therefore used the life expec- 
tancies for the disease free group. Such a judg- 
ment poses a difficulty for the interviewer. 
Furthermore, the resulting TTO-scores might 
not reflect realistic trade-offs. 
Thus the choice of the length of the period t 
to be used in the TTO method is not obvious, 
as, especially in cancer patients, estimates of life 
expectancy are difficult to make. We are not 
aware of studies in the literature that have 
solved (or even discussed) this matter. Our 
findings suggest that patients only give valid 
answers if the TTO is performed using life 
expectancies that they consider realistic. Many 
patients were not willing to trade off off shorter 
durations. Other patients gave erratic answers if 
the time period at stake was clearly longer than 
the length of life they expected, or were willing, 
to live. In such cases, the TTO should perhaps 
be performed in a two step process, the first 
being the assessment of the life expectancy that 
the patient considers realistic. This time span 
(the Subjective Expected Life Years, or SELYs) 
would vary between a maximum equal to the 
statistical life expectancy of the patient, and a 
minimum being defined by the disease adjusted 
life expectancy or by the maximum endurable 
time. These SELYs would subsequently form 
the basis for TTO-questions. 
A second purpose of the study was to test 
whether TTO-scores depend on the length of the 
period t. We hypothesized that subjects would 
be willing to trade off proportionally more off 
longer periods than off shorter due to time 
discounting (see e.g. [lo]). TTO-scores for the 
three periods were indeed significantly different. 
As expected, most was traded off off the long 
period. Many subjects were willing to trade off 
off the long life expectancies, but to a lesser 
extent or not at all off the intermediate and 
short life expectancies. There results thus indi- 
cate a violation of the assumption of pro- 
portional time trade-off. This has also been 
found by Sackett and Torrance [I I] in healthy 
subjects, and by Stalpers [12] in students, but 
not by Hall [13] in healthy women and women 
with breast cancer. 
A violation of the proportionality assumption 
invalidates the calculation of a TTO-score x/t 
and subsequent application of this score to 
periods other than tin QALY-calculations. This 
has been the motivation for Mehrez and Gafni 
to develop the Healthy Years Equivalent (HYE) 
as an alternative to QALYs [14, 151. As shown 
by Johannesson et al. [16], however, the HYE 
can be obtained directly from a TTO-question 
which is less elaborate than the two-stage lottery 
of the HYE. The price to pay for either the HYE 
or such a TTO is an increased complexity: 
trade-offs need to be assessed for all possible 
durations of health states in a profile. A more 
feasible solution seems that proposed by Johan- 
nesson et al. in the same paper: the utility for 
healthy life years (and thus for each possible x) 
is estimated from a utility function constructed 
by means of certainty equivalents as done by 
McNeil et al. [17]. 
Originally we had thought it might be poss- 
ible to construct a function from the three data 
points. This would have permitted the adjust- 
ment of TTO-scores for one period of time to 
other periods of time. However, as the majority 
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of subjects were either not willing to trade off at 
all, or would only trade off off the long period, 
we abandoned this idea. 
It can be argued that the only period to be 
used validly in the TTO is the subject’s life 
expectancy (or better: subjective expected life 
years). The argument here is that other periods 
are not part of the endowment of the subject 
and a meaningful trade-off can therefore not be 
made. If only the subject’s life expectancy can be 
used, however, this first way (intra-respondent) 
in which we-among others-have tried to test 
the proportionality assumption, is biased. 
One has to resort to other ways to test this 
assumption. 
A second way in which we evaluated the 
interdependence of TTO-scores and period was 
by testing whether people in the same health 
state but with longer life expectancies were more 
willing to trade off than people with shorter life 
expectancies. The hypothesis of a positive corre- 
lation between life expectancy and proportion 
traded off did not hold true. On the one hand, 
the lack of a correlation between life expectancy 
and trade-off might be due to a lack of variation 
in TTO-scores (the median for patients treated 
with curative intent being 1.00 or slightly less). 
On the other hand in might be due to other 
factors that we did not control for. For instance, 
willingness to trade might be a personal charac- 
teristic associated with age, making it imposs- 
ible to test independence in this way. 
It is remarkable that many subjects were not 
willing to trade off at all, even though from the 
viewpoint of a healthy subject their quality of 
life was impaired. In the recurrent cancer group 
many patients were willing to trade off off the 
long and intermediate periods, but not off the 
short period, although for them this was prob- 
ably the most realistic life expectancy. Fryback 
et al. [ 181 also found a population median 
TTO-score of 1 .OO when using the remaining life 
expectancy, indicating that at least 50% of the 
respondents would trade off no life years for 
remediation of their health problems. The sensi- 
tivity of the method to decreases in utilities for 
impaired health might be lower for patients than 
for healthy subjects. In a former study [3] we 
found that cured (healthy) testicular cancer 
patients assigned lower scores to hypothetical 
health states related to testicular cancer, than 
the patients in the present study did to their own 
situations. It has usually been found that utili- 
ties from patients are higher than those from 
healthy subjects [1 1, 191. This may imply a 
difference in sensitivity has implications for the 
relevance of the method in medical decision 
making as compared to that in technology 
assessment. In technology assessment it is cus- 
tom to use the values of healthy subjects-who 
are to pay the insurance premiums-in the 
analysis [20]. In medical decision making, where 
one wants to evaluate the utility of outcomes of 
treatment decisions in the groups that have 
experienced those outcomes to optimize treat- 
ment, patients’ utilities are assessed. 
In conclusion, we found that the TTO was 
feasible in the actual situation of cancer patients 
treated with curative intent. In patients with an 
incurable cancer, problems were encountered 
with respect to the choice of the life lengths to 
be used. A solution might be to assess from the 
patient the life expectancy he or she considers 
realistic (the SELY), and to use this as the 
period t in the TTO. 
We found a violation of the assumption of 
proportional time trade-off when comparing 
scores obtained for three periods. Whether this 
was due to time discounting or to the use of 
periods other than the subjects’ life expectancies 
or life expectancies they considered realistic, we 
cannot tell. 
In patients the method seems not very sensi- 
tive to detect decreases in utility due to impaired 
health. Only subjects with a very poor health 
state were willing to trade off, but not so much 
off the life expectancy that was probably theirs, 
but off a hypothetical longer life expectancy. 
Patients who had been or were treated with 
curative intent were very unwilling to trade off. 
The majority of patients seemed to have ac- 
cepted their disease and were not willing to 
trade off life years for the remediation of the 
remaining problems related to this disease. 
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APPENDIX 
Motivations given for TTO scores or for incapability to 
answer: 
(1) Religious, e.g. “Answer a fool according to his folly. .” 
(Proverbs 26, 45, Moffat translation); “Life will be 
taken when time has come”. In total, four respondents 
made religious comment, of which two refused to give 
a score. 
(2) Nature of task. Two respondents refused because they 
thought the questions nonsensical. 
(3) Maximal Endurable Time. Three respondents felt that 
one or more of the periods offered exceeded the time 
they would be able to endure in their health state, 
which made the task impossible. 
(4) Advanced age. Three subjects thought the period 
offered in the health state of the week before too long, 
and preferred a shorter life expectancy. Therefore they 
were very willing to trade, but the objective of the 
tradeoff was not to obtain better health, but simply to 
live less long. 
(5) Adaptation. Two subjects remarked that they had 
become used to their situation and therefore were not 
willing to trade. 
(6) Personal circumstances: One respondent would not 
trade on the short term because she had small children 
living at home. Willingness to trade started at the 
period of time at which the youngest would be grown 
up. 
